THE TAPE
BDX · Medical Instruments · $59.0B

Becton, Dickinson and Co.

$216.47▼ −0.72%
Last close
Relative strength
85RS
of 99, against every stock▲ +11 on the month
Powering up
Front line
+15.9%
six months against Medical Instruments
52-week range
−1.8%
from the high
$140.11$220.36
Setup
flat baseclimbing
+12.1%
against the pivot at $193.07
No report date on the calendar.
Growth FLATProof PENDING
Quarter to Jun 30, revenue +5% on a year ago
11/16 O 219.45 H 220.36 L 215.64 Vol 1.5M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS85
vs pivot+12.12%
Tightening1.09×
Dry-up0.89×
Up/down vol0.02
From high2%
climbing7 of 9checks
Previous breakout trailed out ▼ −4.58% in Aug
Powering up
Support and resistance
Support below
$192.03
-11.3% · tested 4× · last 13 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 7.4 weeks and fell 9% from its ceiling at its deepest. The pivot is $193.07, and the stock closed 12.1% above that pivot. Its relative strength rating is 85.

Against its industry
Front lineAhead of its industry over one, three and six months, in an industry fully aligned and ahead of the S&P 500.
One month against its industry
+8.4%
Three months against its industry
+19.6%
Six months against its industry
+15.9%

Read against an equal-weighted index of Medical Instruments, which is +31.0% against the S&P 500 over six months Fully aligned.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap
24
days
Ex-dividend in 24 days
Dec 10, 2026
  1. Ex-dividendconfirmedin 24d
    Ex-dividend date
    Dec 10, 2026
How it moves on earnings

On average 8.0% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$23.3B
+5.4% year on year
Operating margin
10.7%
Net margin
4.0%
Free cash flow
—
Price to sales
2.54×
Price to earnings
62.7×

Twelve months to Jun 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 5

The prior quarter: the 10-Q for this report is not filed yet.

Key takeaway
A mixed quarter: the numbers do not agree.
Revenue
$5.0B
+5.7% QoQ · +5.4% YoY
Gross margin
—
Net income
$377.0M
Positive
Free cash flow
—

What the numbers say

  • Revenue +5.4% year over year, +5.7% on the quarter
  • Good: Profitable: net income $377M, operating margin 13.3%
  • Good: Share count -4.2% in a year: buying back
  • Weak: Net debt $16.10B · cash $708M
Revenue by quarter
Free cash flow
Net income
shares -4.2% in a year · net debt $16.1B
Final read
Growth: FLAT · Economic proof: PENDING
Key question: What turns the cash flow positive?
The next test is the balance sheet: net debt $16.10B · cash $708M.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 1 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 added, 2 sold out.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Reported resultsFiling · 2026-11-06
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
New 52-week highTape · 2026-11-06
2.3x vol
Mixed: stocks have lagged random stocks by 0.9% over three sessions, not consistently enough to call (554 cases over 52 nights). Against their own sector they have lagged by 2.1%.
Unusual volumeTape · 2026-11-06
3.5 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
New 52-week highTape · 2026-11-05
2.8x vol
Mixed: stocks have lagged random stocks by 0.9% over three sessions, not consistently enough to call (554 cases over 52 nights). Against their own sector they have lagged by 2.1%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-05
above 20d & 50d on 2.8x volume at 209.19
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-11-05
+5.6%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Unusual volumeTape · 2026-11-05
7.0 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Earnings comingEvent · 2026-11-04
reports 2026-11-05 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
12
$2,663,319 total

Sold: Polen Thomas E Jr, Feld Michael, Goette Roland, Garrison Michael David.

Not counted above: 11 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-11-05 Polen Thomas E Jr · Chairman, CEO and President, Directoroption exercise20,239$3,621,567
2026-11-05 Polen Thomas E Jr · Chairman, CEO and President, Directordisposition to issuer17,246$3,621,660
2026-11-05 Polen Thomas E Jr · Chairman, CEO and President, Directorsell2,993$628,530
2026-10-26 Feld Michael · EVP, Chief Revenue Officersell76$15,058
2026-09-28 Feld Michael · EVP, Chief Revenue Officersell76$13,961
2026-09-02 Roque Vitor · EVP & Chief Financial Officerwithheld for tax190
2026-08-26 Feld Michael · EVP, Chief Revenue Officersell165$31,101
2026-08-20 Feld Michael · EVP, Chief Revenue Officerwithheld for tax1,049

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

The geometry
Level · floor$206.02
Wrong above$221.50
Measured target · the shape's own height$184.07
Reward against risk1.4×
Lines closed · of the gap they started with19%
Through to the apex70%
Touches · swing points the lines are drawn through8 up · 7 down
Length12.2 weeks
What lines up

7 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy1
Buy8
Hold6
Sell0
Strong sell1

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray
7w · 9%

The most recent of 3 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Becton, Dickinson and Co. (BDX) — The Tape